唐人神集团股份有限公司 2024 年度独立董事述职报告 陈小军 各位股东及代表： 大家好！ 本人作为唐人神集团股份有限公司（以下简称"公司"）的独立董事，2024 年度，本人严格按照《证券法》《公司法》《上市公司独立董事管理办法》《上 市公司治理准则》《深圳证券交易所股票上市规则》《深圳证券交易所上市公司 自律监管指引第 1 号—主板上市公司规范运作》等法律法规，以及《公司章程》 《独立董事制度》和《独立董事专门会议工作制度》的规定，独立、勤勉地履行 独立董事义务，切实维护公司的整体利益和全体股东尤其是中小股东的合法权益， 现将本人 2024 年度履职情况报告如下： 一、独立董事的基本情况 1、基本情况 陈小军，女，中国国籍，无境外永久居留权，1972 年出生，汉族，中共党 员，博士研究生，目前担任湖南农业大学教授，2022 年 6 月起至今担任公司独 立董事。 2、独立性情况说明 作为公司独立董事，本人已向公司递交了独立性自查情况报告。本人严格遵 守法律法规和《公司章程》等有关规定，均未在公司担任除独立董事、董事会专 门委员会委员以外的任何职务，也未在公司主要股东公司担任任何职务，与公司 以及主要股东之间不 ...

唐人神集团股份有限公司 长效激励基金管理办法 第一章 总则 第一条 为充分调动和发挥唐人神集团股份有限公司（以下简称"公司"、" 唐人神集团"）核心骨干员工的积极性，秉持"高目标、高增长、高收入"的薪酬 原则，增强核心骨干员工对实现公司持续健康发展的责任感、使命感，凝聚优 秀人才，提升公司综合竞争力，从而为股东带来更多、更持久的投资回报，制 定《唐人神集团股份有限公司长效激励基金管理办法》（以下简称《激励基金 管理办法》、本办法），设立公司长效激励基金。 第二条 本办法遵循的原则： （一）坚持奖励和约束相结合； （二）坚持股东利益、公司利益和激励对象的个人利益相结合； （三）符合法律、法规、规范性文件和《公司章程》的相关规定。 第三条 本激励基金是在各业务板块（饲料、养殖、肉品）达到本办法约定 的条件后予以计提，用来奖励给公司管理、技术骨干以及经认定应当奖励的其 他员工且激励对象需要满足八年服务年限后方可实际获取相应奖励。 第二章 激励对象的范围 第五条 本次长效激励基金的参与对象应为符合以下条件的公司正式员工： 第四条 本激励基金是公司现有薪酬管理制度之补充奖励资金，本办法与公 司现有薪酬管理制度并行实施。 ...

唐人神集团股份有限公司 董事会议事规则 第一章 总 则 第一条 为明确唐人神集团股份有限公司（以下简称"公司"）董事会的职 责权限，规范董事会的组织和行为，确保董事会的工作效率和科学决策，根据《中 华人民共和国公司法》（以下简称"公司法"）和《唐人神集团股份有限公司章 程》（以下简称"公司章程"）的规定，制定本规则。 第二条 董事会是公司的常设机构，对股东会负责，执行股东会决议，维护 公司和全体股东的利益，负责公司发展目标和重大经营活动的决策。 第三条 董事会下设董事会办公室（证券部门），处理董事会日常事务。 第四条 董事会会议分为定期会议和临时会议。 第五条 董事会每年至少召开两次定期会议，由董事长召集和主持，于会议 召开 10 日前通知全体董事。 第六条 代表十分之一以上表决权的股东、三分之一以上董事或者审计委员 会，可以提议召开董事会临时会议。董事长应当自接到提议后 10 日内，召集和 主持董事会会议。 召开董事会临时会议，董事会办公室应当在会议召开 3 日以前通知全体董事； 但在参会董事没有异议或事情比较紧急的情况下，不受上述通知期限的限制，可 以随时通知召开。 第七条 董事会会议由董事长召集和主持； ...

经核查，根据独立董事赵宪武先生、张南宁先生、陈小军女士的任职经历以 及签署的相关自查文件，上述人员未在公司担任除独立董事、董事会专门委员会 委员以外的任何职务，也未在公司主要股东公司担任任何职务，与公司以及主要 股东之间不存在利害关系或其他可能妨碍其进行独立客观判断的关系，不存在影 响独立董事独立性的情况，符合《上市公司独立董事管理办法》《深圳证券交易 所上市公司自律监管指引第 1 号—主板上市公司规范运作》中对独立董事独立性 的相关要求。 唐人神集团股份有限公司董事会 二〇二五年四月二十八日 唐人神集团股份有限公司董事会 关于独立董事独立性自查情况的专项报告 根据《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》《深圳 证券交易所上市公司自律监管指引第 1 号—主板上市公司规范运作》等要求，唐 人神集团股份有限公司（以下简称"公司"）董事会，就公司在任独立董事赵宪 武先生、张南宁先生、陈小军女士的独立性情况进行评估并出具如下专项意见： ...

唐人神集团股份有限公司 章 程 二〇二五年四月 | 第一章 | 总 | 则 2 | | | --- | --- | --- | --- | | 第二章 | | 经营宗旨和范围 3 | | | 第三章 | 股 | 份 4 | | | 第一节 | | 股份发行 | 4 | | 第二节 | | 股份增减和回购 | 4 | | 第三节 | | 股份转让 | 6 | | 第四章 | | 股东和股东会 6 | | | 第一节 | | 股东的一般规定 | 6 | | 第二节 | | 控股股东和实际控制人 | 9 | | 第三节 | | 股东会的一般规定 | 10 | | 第四节 | | 股东会的召集 | 13 | | 第五节 | | 股东会的提案与通知 | 14 | | 第六节 | | 股东会的召开 | 16 | | 第七节 | | 股东会的表决和决议 | 18 | | 第五章 | 董事会 | 21 | | | 第一节 | | 董事的一般规定 | 21 | | 第二节 | | 董事会 | 24 | | 第三节 | | 独立董事 | 28 | | 第四节 | | 董事会专门委员会 | 32 | | 第五节 | | 董事会秘书 ...

Business Performance - The company's operating revenue for 2024 was approximately ¥24.34 billion, a decrease of 9.67% compared to ¥26.95 billion in 2023[31]. - The net profit attributable to shareholders for 2024 was approximately ¥355.42 million, a significant increase of 123.29% from a loss of ¥1.53 billion in 2023[31]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥296.79 million, up 119.72% from a loss of ¥1.51 billion in 2023[31]. - The net cash flow from operating activities for 2024 was approximately ¥936.35 million, representing a 74.83% increase from ¥535.58 million in 2023[31]. - The basic earnings per share for 2024 was ¥0.248, a recovery from a loss of ¥1.0916 in 2023, marking a 122.72% improvement[31]. - The total assets at the end of 2024 were approximately ¥17.99 billion, an increase of 5.75% from ¥17.01 billion at the end of 2023[31]. - The net assets attributable to shareholders at the end of 2024 were approximately ¥5.89 billion, up 7.14% from ¥5.50 billion at the end of 2023[31]. - The company achieved operating revenue of CNY 24.343 billion, a year-on-year decrease of 9.67%[45]. - The net profit attributable to shareholders increased by 123.29% to CNY 355 million[45]. - The company reported a total of 4.3362 million pigs sold, representing a year-on-year growth of 16.80%[45]. Cost Management and Efficiency - The company has implemented a comprehensive disease prevention management system and cost management to enhance production efficiency and reduce costs[13]. - The company is enhancing its production processes by utilizing automated feeding and environmental control systems to improve operational efficiency[13]. - The company has adopted a centralized procurement strategy for raw materials to enhance bargaining power and control costs, ensuring a stable supply chain[10]. - The company reduced the cost of weaned piglets by 46.34 yuan per head compared to the previous year, with expectations for further cost reductions through ongoing investments in breeding and disease control[46]. - The company’s cost of pig fattening decreased by CNY 1.59 per kilogram year-on-year[45]. - The total operating costs decreased by 15.27% to 22,208,823.6 million, with feed costs accounting for 63.31% of total operating costs[73]. Market and Product Development - The company is investing in research and development of meat products to address food safety concerns and improve product quality[15]. - The company is expanding its market presence through strategic partnerships and investments in new technologies[6]. - The company is developing the "Xiangxiang Pig" premium fresh brand through technological innovations in nutrition formulation and breeding, promoting it via both online and offline channels[47]. - The company is focusing on optimizing its digital management system to enhance operational efficiency and decision-making capabilities[17]. - The company plans to expand its "company + farmer" model in regions like Hunan, Guangdong, and Guangxi to enhance profitability[45]. - The company is focusing on new product development, with an investment of 3.49 million in the latest quarter for research and development[109]. Financial Management and Fundraising - The company plans not to distribute cash dividends or issue bonus shares for the current period[18]. - The company has established a comprehensive management system that integrates various operational aspects to ensure steady development[61]. - The company has raised a total of RMB 299,999,997.00 from the issuance of 45,454,545 shares at a price of RMB 6.60 per share, with a net amount of RMB 292,991,294.69 after deducting issuance costs[103]. - The company has a remaining balance of 69,195.04 CNY in unused raised funds, which is stored according to relevant regulations[97]. - The company has redirected RMB 32 million from the "Chongqing Xiangda Biotechnology Co., Ltd. Animal Nutrition Biological Feed Research and Production Base Construction Project" to its subsidiary[114]. Governance and Compliance - The company has established a comprehensive governance structure and internal control system, adhering to relevant laws and regulations to enhance operational standards[145]. - The company is committed to maintaining independent operations, fully separating its business and financial activities from its controlling shareholder[146]. - The company has implemented various internal management systems, including major information reporting and investor relations management[145]. - The company held a total of 6 shareholder meetings in 2024, all conducted legally with the presence of a witnessing lawyer[146]. - The company emphasizes the independence of its operations from controlling shareholders in business, assets, personnel, and finance[150]. Research and Development - The company is focusing on digital transformation to reduce overall breeding costs and improve production and health metrics through AI and IoT technologies[60]. - The company has invested in advanced breeding systems and established partnerships with institutions like the Chinese Academy of Sciences to enhance its breeding capabilities[57]. - The company’s R&D personnel increased to 862 in 2024, a growth of 2.50% compared to 841 in 2023[80]. - R&D investment decreased by 23.34% to ¥101,524,602.56 in 2024 from ¥132,429,246.50 in 2023, representing 0.42% of operating revenue[80]. - The company is committed to enhancing its research and development capabilities in animal nutrition and feed production[119]. Employee Management and Training - The total number of employees at the end of the reporting period is 11,805, with 1,137 in the parent company and 10,668 in major subsidiaries[184]. - The training program in 2024 focused on digital transformation, talent development, and practical skills enhancement, with over 3,093 training sessions covering 120,000 participants and a skill qualification rate of 98%[188]. - The company has implemented a stock option incentive plan, with 403 participants eligible for 6,126,520 stock options in the second exercise period and 50 participants eligible for 822,100 stock options in the first reserved exercise period[193]. - The company emphasizes a "learning organization" ecosystem to support high-quality development through continuous training optimization[188]. - The company's compensation policy is based on annual business plans and performance contributions, aiming for external competitiveness and internal fairness[185].

Financial Performance - The company's revenue for Q1 2025 was CNY 5,973,387,459.78, representing a 22.40% increase compared to CNY 4,880,079,621.11 in the same period last year[4]. - The net loss attributable to shareholders decreased by 60.99% to CNY -77,051,603.93 from CNY -197,512,579.11 year-over-year[4]. - The net cash flow from operating activities improved significantly, reaching CNY 123,149,306.93, a 184.58% increase from CNY -145,605,740.39 in the previous year[4]. - Total operating revenue for the current period reached ¥5,973,387,459.78, an increase of 22.4% compared to ¥4,880,079,621.11 in the previous period[23]. - The net profit for the current period was a loss of ¥80,277,338.74, an improvement from a loss of ¥224,366,712.75 in the previous period[24]. - The total comprehensive income for the period was -80,277,338.74 CNY, compared to -224,366,712.75 CNY in the previous period, indicating an improvement[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 18,293,202,363.67, up 1.70% from CNY 17,987,160,209.45 at the end of the previous year[5]. - Current liabilities totaled ¥6,755,703,894.79, an increase from ¥6,257,475,895.75 in the prior period[21]. - Non-current liabilities decreased to ¥5,084,654,087.48 from ¥5,137,678,735.45 in the previous period[21]. - The company's total liabilities increased, with notes payable rising by 36.97% to CNY 740,702,044.00 due to increased procurement[9]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 80,593, with the largest shareholder holding 11.24% of the shares[12]. - The company repurchased 5,617,400 shares, accounting for 0.39% of the total share capital, with a total transaction amount of CNY 28,998,197, at a price range between CNY 4.87 and CNY 5.52 per share[15]. - The company has no significant changes in the shareholding structure of the top 10 shareholders due to margin trading activities[14]. Cash Flow - As of March 31, 2025, the company's cash and cash equivalents amounted to CNY 2,373,528,116.93, an increase from CNY 2,304,501,756.88 at the beginning of the period, reflecting a growth of approximately 2.9%[19]. - Cash inflow from operating activities was 6,376,263,024.95 CNY, up from 5,015,017,110.45 CNY in the previous period, representing a 27.1% increase[26]. - Cash inflow from investment activities was 675,633,594.88 CNY, compared to 351,441,175.68 CNY in the previous period, showing a 92.2% increase[27]. - The ending cash and cash equivalents balance was 2,087,037,485.40 CNY, down from 2,221,986,906.27 CNY in the previous period[27]. Operational Insights - The company reported a significant decrease in other income, down 41.10% to CNY 7,017,649.89, primarily due to reduced government subsidies[11]. - The company experienced a 68.82% reduction in asset disposal gains, reporting CNY -6,808,434.07 compared to CNY -21,834,638.72 in the previous year[11]. - The company's accounts receivable increased to CNY 333,888,202.28 from CNY 281,807,300.66, representing a growth of about 18.5%[19]. - The company's trading financial assets increased to CNY 22,255,080.61 from CNY 16,817,462.12, indicating a growth of about 32.5%[19]. - Research and development expenses were ¥31,638,376.28, a decrease from ¥44,890,002.39 in the previous period[24]. - The company reported an investment income of ¥5,724,708.16, significantly higher than ¥2,292,807.37 in the previous period[24]. Strategic Developments - The company has not disclosed any new product developments or market expansion strategies in the current report[14]. - The company is not currently engaged in any mergers or acquisitions as per the latest financial report[14]. - There are no significant changes in the company's operational strategies mentioned in the earnings call[14]. - The company's weighted average return on equity improved to -1.32% from -3.66% year-over-year[4]. - The company's basic and diluted earnings per share improved by 60.99%, both standing at CNY -0.0538 compared to CNY -0.1379 in the same period last year[4]. Audit Status - The company’s first quarter report was not audited[29].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002567 证券简称：唐人神 公告编号：2025-028 唐人神集团股份有限公司 关于子公司参与投资产业基金合伙企业的进展公告 统一社会信用代码：91440101MA5A3EJQ33 名称：广州大消费品壹期产业投资基金合伙企业（有限合伙） 类型：有限合伙企业 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 唐人神集团股份有限公司（以下简称"公司"）于2017年11月24日召开了第七届董事会第二十六次会议， 审议通过了《关于子公司参与投资产业基金合伙企业的议案》，同意全资子公司深圳前海唐人神投资有 限公司（以下简称"前海唐人神"）作为有限合伙人以自有资金50,000,000元投资广州大消费品壹期产业 投资基金合伙企业（有限合伙）（以下简称"大消费品基金"）。大消费品基金历次变更情况详见公司刊 登在巨潮资讯网（www.cninfo.com.cn）的《关于子公司参与投资产业基金合伙企业的进展公告》。 2025年3月10日，大消费品基金召开合伙人会议，决议：大消费品基金认缴出资额由200,000,000元减 ...

证券代码：002567 证券简称：唐人神 公告编号：2025-027 唐人神集团股份有限公司 关于第三期员工持股计划 第一个锁定期届满的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 唐人神集团股份有限公司（以下简称"公司"、"唐人神"）分别于 2024 年 3 月 6 日、2024 年 3 月 26 日召开第九届董事会第二十三次会议、2024 年第二 次临时股东大会，审议通过了《关于<第三期员工持股计划（草案）>及摘要的议 案》、《关于<第三期员工持股计划管理办法>的议案》、《关于提请股东大会授 权董事会办理公司第三期员工持股计划相关事宜的议案》。鉴于公司第三期员工 持股计划第一个锁定期于 2025 年 4 月 11 日届满，根据中国证券监督管理委员会 《关于上市公司实施员工持股计划试点的指导意见》及《深圳证券交易所上市公 司自律监管指引第 1 号-主板上市公司规范运作》相关规定，现将第三期员工持 股计划第一个锁定期届满后的相关情况公告如下： 一、本次员工持股计划持股情况和锁定期 （一）本次员工持股计划持股初始情况 本次员工持股计划的股票来源为公司回购 ...